EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pulmonarom® promotes TLR-related and interferon-related antiviral responses during influenza A (H1N1 and H3N2) infection in human monocyte-derived dendritic cells

Sandra Georgina Solano-Gálvez, Juan A Hernández-Aceves, Alberto García Lozano, Arturo A Wilkins-Rodríguez, Diego Alexander Rojas Ortega, Antonio Ibarra, Exsal Manuel Albores Méndez, Edda Sciutto, Laila Gutiérrez-Kobeh, Horacio Merchant Larios, Carlos Cabello-Gutiérrez, Gladis Fragoso und 1 weitere

Frontiers in Cellular and Infection Microbiology · 18.08.2026 · 16

DOI: 10.3389/fcimb.2026.1891757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 18.08.2026. Verfasst von Sandra Georgina Solano-Gálvez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Investigación Universidad Nacional Autónoma de México - Instituto Nacional de Cardiología (UNAM-INC), División de Investigación, Facultad d…. Hauptthemen laut MEDLINE: Dendritic Cells, Influenza A Virus, H3N2 Subtype, Influenza A Virus, H1N1 Subtype, Toll-Like Receptors. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanofi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bacterial lysates have been associated with improved host defense against respiratory infections; however, their mechanisms of action remain incompletely understood. Based on our previous in vitro work showing that Pulmonarom ® activates human monocyte-derived dendritic cells (moDCs) and induces TLR- and cytokine-related responses consistent with innate immune activation, we evaluated its immunomodulatory effect during influenza A virus infection using two in vitro conditions: pre-exposure and post-infection treatment. Materials and methods Human monocytes obtained from buffy coats were differentiated into moDCs. Lyophilized Pulmonarom ® was quantified as total protein and evaluated at 0.01, 0.1, or 0.5 µg/mL in 24-well cultures containing 1 × 10 6 moDCs in 1 mL medium per well. In the pre-exposure condition, moDCs were incubated with Pulmonarom ® for 1 h before infection with influenza A/H1N1 or A/H3N2 virus. In the post-infection treatment condition, Pulmonarom ® was added after the 1-h infection period. TLRs and cytokine expression were evaluated by flow cytometry. Changes in hemagglutinating activity were evaluated by hemagglutination inhibition assay and virus infectivity was evaluated with a MDCK plaque cell assay.

Results

Under both pre-exposure and post-infection treatment conditions, Pulmonarom ® enhanced MHC class II expression and improved cell viability following infection with either A/H1N1 or A/H3N2 virus, consistent with moDC activation. In hemagglutination inhibition assays, Pulmonarom ® was associated with reduced hemagglutinating activity in culture supernatants. Similarly, plaque infectivity assays demonstrated that Pulmonarom ® , administered either before or after infection, decreased the number of lysed cells within plaques, with a more pronounced effect observed under post-infection treatment. These immunomodulatory changes were accompanied by increased cytokine secretion and the induction of type I interferon-related responses.

Conclusions

Pulmonarom ® modulated human moDC responses during in vitro infection with influenza A/H1N1 and A/H3N2 virus. These findings extend our previous observations on Pulmonarom ® -induced innate immune activation in human dendritic cells and support further analysis of this bacterial lysate as a host-directed immunomodulatory strategy. Future studies should be evaluated to determine infectious viral titers, TLRs dependency, dendritic-cell maturation markers, and downstream T-cell responses; using plaque assay with sensible cells, receptor-blocking approaches, expanded maturation and characterization panels, and functional co-culture assays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsInfluenza A Virus, H3N2 SubtypeInfluenza A Virus, H1N1 SubtypeToll-Like ReceptorsInterferonsInfluenza, HumanImmunologic FactorsHumansCells, CulturedCytokinesMonocytesBacterial LysatesAnimalsDogsToll-Like Receptor Agonists

Stichwörter der Autor:innen

Pulmonarom®TLRantiviraldendritic cellsimmunomodulatorsinfluenza virus (H1N1 and H3N2)interferonpostbiotic

Substanzen

CytokinesToll-Like ReceptorsBacterial LysatesInterferonsImmunologic FactorsToll-Like Receptor Agonists

Autor:innen und Institutionen

  • Unidad de Investigación Universidad Nacional Autónoma de México - Instituto Nacional de Cardiología (UNAM-INC), División de Investigación, Facultad de Medicina, Ciudad de México, Mexico.
  • Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
  • Laboratorio de Inmunobiología, Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
  • Centro de Investigación en Ciencias de la Salud (CICSA) Facultad de Ciencias de la Salud Universidad Anáhuac México Norte, Huixquilucan, Mexico.
  • Escuela Militar de Graduados en Sanidad Universidad del Ejército y Fuerza Aérea Secretaría de la Defensa Nacional México, Ciudad de México, Mexico.
  • Laboratorio de Biología Celular y Fisiología Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.

Förderung

  • Sanofi

Zitieren

APA

Solano-Gálvez, S. G., Hernández-Aceves, J. A., García Lozano, A., Wilkins-Rodríguez, A. A., Rojas Ortega, D. A., Ibarra, A., Albores Méndez, E. M., Sciutto, E., Gutiérrez-Kobeh, L., Merchant Larios, H., Cabello-Gutiérrez, C., Fragoso, G., & Vázquez-López, R. (2026). Pulmonarom® promotes TLR-related and interferon-related antiviral responses during influenza A (H1N1 and H3N2) infection in human monocyte-derived dendritic cells. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1891757

Vancouver

Solano-Gálvez SG, Hernández-Aceves JA, García Lozano A, Wilkins-Rodríguez AA, Rojas Ortega DA, Ibarra A, et al. Pulmonarom® promotes TLR-related and interferon-related antiviral responses during influenza A (H1N1 and H3N2) infection in human monocyte-derived dendritic cells. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1891757

BibTeX
@article{SolanoGlvez2026,
  author = {Solano-Gálvez, Sandra Georgina and Hernández-Aceves, Juan A and García Lozano, Alberto and Wilkins-Rodríguez, Arturo A and Rojas Ortega, Diego Alexander and Ibarra, Antonio and Albores Méndez, Exsal Manuel and Sciutto, Edda and Gutiérrez-Kobeh, Laila and Merchant Larios, Horacio and Cabello-Gutiérrez, Carlos and Fragoso, Gladis and Vázquez-López, Rosalino},
  title = {Pulmonarom® promotes TLR-related and interferon-related antiviral responses during influenza A (H1N1 and H3N2) infection in human monocyte-derived dendritic cells},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1891757}
}
Kostenlos starten →